Skip to content

New insights into isoprene degradation: Leipzig study clarifies atmospheric processes

  • News

Researchers at the Leibniz Institute for Tropospheric Research (TROPOS) in Leipzig have discovered new reaction pathways in the atmospheric degradation of isoprene that could be significant for the formation of organic aerosols worldwide. The findings, published in Nature Communications, provide a deeper understanding of atmospheric chemistry. Isoprene, a compound emitted by deciduous forests, is one of the most important non-methane compounds, accounting for 600 million tons of carbon annually. It is degraded in the gas phase almost exclusively by hydroxyl radicals, forming peroxy radicals. These processes, especially in the tropics, are crucial, but the reaction pathways have not been fully understood until now. In experiments under atmospheric conditions, the TROPOS team used highly sensitive mass spectrometry to detect peroxy radicals and stable products. The investigations confirmed existing knowledge but identified new C4 and C5 products and highly oxidized peroxy radicals (C5H9O8 and C5H9O9) for the first time, which form via autoxidation within seconds. Despite a low molar yield of 0.3%, the enormous amount of isoprene could lead these radicals...

FAQ: What happened to J. Craig Venter?

J. Craig Venter is a world-renowned American biochemist, geneticist, and entrepreneur who played a key role in sequencing the human genome and pioneered synthetic biology. Below, we answer the most frequently asked questions about his career and current activities. 1. Who is J. Craig Venter? J. Craig Venter (born October 14, 1946, in Salt Lake City, Utah) is an American scientist and entrepreneur. He became known for his leading role in sequencing the human genome as part of the Human Genome Project and as the founder of Celera Genomics, which published an early version of the human genome in 2001. Venter also founded the J. Craig Venter Institute (JCVI) and was involved in the development of the first synthetic bacterium. 2. What has J. Craig Venter achieved? Venter's most significant achievements include: 3. What is J. Craig Venter doing today? 4. Did Venter… 

Nuclear War in Europe: Medical Catastrophe and Geopolitical Framework 2025

A nuclear war in Europe would trigger an unprecedented medical and humanitarian crisis, with consequences lasting for generations. The effects range from immediate injuries from explosions and radiation to long-term health damage and global food shortages. This LabNews report is based on peer-reviewed studies, concrete data, and the geopolitical situation in May 2025 to analyze the medical consequences of such a conflict in detail. Immediate Medical Consequences The detonation of a medium-sized nuclear warhead (e.g., 100 kilotons of TNT equivalent) over a major city like Berlin or Warsaw would cause tens of thousands of deaths and injuries within seconds. According to a study by Princeton University (2020), in such a scenario in a city of 3 million inhabitants, approximately 90,000 people could be killed instantly and 150,000 injured. The blast wave, reaching speeds of up to 800 km/h, destroys buildings within a 5 km radius and causes... 

Mazdutid: China attacks the Western weight-loss injection

  • News

Breakthrough in Obesity Treatment – Innovent’s Mazdutide Published in NEJM Suzhou, China – Innovent Biologics, Inc. (“Innovent”), a leading biopharmaceutical company, has achieved a significant milestone: the results of the Phase 3 GLORY-1 study for Mazdutide, a dual glucagon (GCG)/GLP-1 receptor agonist, have been published in the prestigious New England Journal of Medicine (NEJM). This marks a historic moment as it is the first time an innovative therapy for metabolic diseases developed in China is featured in this top-tier journal. The study, with lead authors Professor Linong Ji (Peking University People’s Hospital) and Professor Jiang Hongwei (First Affiliated Hospital of Henan University of Science and Technology), demonstrates the efficacy of Mazdutide in Chinese adults with overweight or obesity. Professor Ji and Dr. Lei Qian from Innovent served as corresponding authors. Mazdutide, the world’s first dual GCG/GLP-1 receptor agonist submitted for marketing approval, not only led to significant reductions…

Mathematician at the Helm: Nicu?or Dan Leads Romania into a New Era

  • News

On May 26, 2025, Romania inaugurated an unusual president: Nicu?or Dan, an independent mathematician who previously served as the mayor of Bucharest. His rise marks a turning point for the country, which has struggled with corruption, economic instability, and political polarization for decades. Dan’s election as president, after a thrilling runoff against right-wing populist candidate George Simion, was widely seen as a signal for a pro-European, reform-oriented course. Particularly noteworthy is Dan’s academic background: a two-time gold medalist at the International Mathematical Olympiad and a holder of a Ph.D. in mathematics, he brings an analytical mindset to politics that could drive new momentum in the fields of biotechnology, pharmaceuticals, research, and information technology (IT). This newspaper report examines Dan’s career path, his political vision, and the potential benefits of his mathematical approach for Romania’s future, supported by credible sources and peer-reviewed studies. Nicu?or Dan: From Mathematician to President Nicu?or Dan was born in 1969…

Lunit Highlights AI’s Role in Advancing Precision Oncology at ASCO 2025

Lunit (KRX:328130.KQ), a leading provider of AI for cancer diagnostics and therapeutics, today announced that 12 studies featuring its AI-powered digital pathology solution will be presented at the 2025 American Society of Clinical Oncology (ASCO) Annual Meeting, taking place May 30–June 3 in Chicago, IL. Of these, 11 studies will be presented as posters and one as an online publication. One of the featured studies, conducted with Japan’s National Cancer Center Hospital East (NCCE), evaluated HER2 expression in biliary tract cancer (BTC) patients using Lunit’s AI-powered analyzer. The resulting AI scores showed strong agreement with pathologist-assigned IHC scores in a 288-patient screening cohort. Among 29 patients treated with trastuzumab deruxtecan (T-DXd), those with higher levels of HER2-intense tumor cells achieved a higher objective response rate (ORR) of 50%, along with significantly longer progression-free survival and overall survival. The study also found that AI-derived „membrane… 

New Multi-Omics Blood Test Shows Promise for Early Cancer Detection

A groundbreaking study published in the Journal of Molecular Diagnostics reports the successful clinical validation of SeekInCare®, a novel, non-invasive multi-omics blood test designed for the early detection of multiple cancer types. Developed by researchers at SeekIn Inc., SeekInCare integrates advanced genomic, epigenetic, and proteomic analyses to identify cancer at its early stage, offering hope for improved outcomes through earlier intervention. Key Findings

Tens of thousands of children go missing every year in Europe

  • News

Tens of thousands of children go missing every year in Europe, a phenomenon that presents challenges for authorities, organizations, and the public alike. The reasons are diverse, but the data is often incomplete. This report sheds light on the current situation using available statistics, peer-reviewed studies, and European data sources to paint an accurate picture of the problem. Scope of the Problem According to estimates from the European Commission and the organization Missing Children Europe, approximately 250,000 children are reported missing in Europe annually. This equates to about one case every two minutes. This figure includes various categories of missing persons cases, including runaways, parental abductions, unaccompanied minor refugees, and rare cases of criminal kidnappings. An analysis of the 116,000 hotline, operated in 32 European countries, shows that in 2021, around 54,655 calls related to missing children were registered, with approximately 13% of cases involving children who had previously been reported missing… 

Kommentar: Merz’ Kritik an Israel – Ein notwendiger Tonwechsel mit Risiken

  • News

Die deutlichen Worte von Bundeskanzler Friedrich Merz zur israelischen Offensive im Gazastreifen markieren einen bemerkenswerten Einschnitt in der deutschen Nahostpolitik. Beim WDR-Europaforum 2025 sprach Merz Klartext: Die Zivilbevölkerung werde derart in Mitleidenschaft gezogen, dass dies nicht mehr mit dem Kampf gegen die Hamas zu rechtfertigen sei. Angriffe auf zivile Einrichtungen wie ein Kinderheim seien eine „menschliche Tragödie und politische Katastrophe“. Diese Kritik, gepaart mit dem Hinweis auf Verstöße gegen das humanitäre Völkerrecht, bricht mit der bisherigen Zurückhaltung Deutschlands, Israel öffentlich zu tadeln. Sie spiegelt einen Stimmungswechsel wider, der nicht nur in der deutschen Politik, sondern auch international an Dynamik gewinnt. Merz’ Vorstoß ist vor dem Hintergrund der katastrophalen Lage in Gaza zu sehen. Die Weltgesundheitsorganisation (WHO) berichtet von über 1500 Angriffen auf medizinische Einrichtungen seit Beginn des aktuellen Konflikts. Krankenhäuser, Kliniken und Ambulanzen sind weitgehend zerstört oder funktionsunfähig. Betäubungsmittel und… 

Verschärfte Risikobewertung von Ewigkeitschemikalie TFA

Die Bundesstelle für Chemikalien hat mit dem Umweltbundesamt (UBA) und dem Bundesinstitut für Risikobewertung (BfR) die Ewigkeitschemikalie Trifluoressigsäure (TFA) offiziell als fortpflanzungsgefährdend sowie als sehr langlebig und mobil bewertet und ein entsprechendes Einstufungsdossier bei der Europäischen Chemikalienagentur eingereicht. Die Deutsche Umwelthilfe (DUH) begrüßt den Vorstoß und fordert schnelle politische Konsequenzen. TFA gehört zur Gruppe der per- und polyfluorierten Alkylsubstanzen (PFAS) und wird seit Jahren regelmäßig in fast allen deutschen Gewässern nachgewiesen – mit immer steigenden Konzentrationen. TFA wird als Industriechemikalie genutzt, ist aber auch ein Abbauprodukt von mehreren anderen Chemikalien. Das betrifft beispielsweise das fluorierte Kältemittel „R1234yf“, das in fast jeder Autoklimaanlage genutzt wird und damit in riesigen Mengen im Umlauf ist. Zudem gibt es viele Pestizide, die sich in TFA abbauen. Die DUH führt bereits mehrere Verfahren gegen PFAS-Pestizide, die Flufenacet enthalten. Der Einsatz von Flufenacet ist laut UBA…